35 F
New York
Thursday, December 3, 2020

Should Medmen Enterprises Inc (OTCMKTS:MMNFF) Be Back on the Radar?

Must read

Will Marathon Oil Corporation (MRO) Find a Support Level Soon?

Marathon Oil Corporation (MRO) shares are trading at higher $6.06 and the avg recommendation for the stock is Moderate Buy, while the current analyst...

The Forecast Just Changed on Uber Technologies Inc. (NYSE:UBER)

Uber Technologies Inc. (UBER) shares are trading at higher $53.09 and the avg recommendation for the stock is Strong Buy, while the current analyst...

Is the Rough Ride Over for Bank of America Corporation (BAC)

Bank of America Corporation (BAC) shares are trading at higher $29.06 and the avg recommendation for the stock is Moderate Buy, while the current...

Wells Fargo & Company (WFC)’s Stock is Jumping, Here is Why

Wells Fargo & Company (WFC) shares are trading at higher $28.87 and the avg recommendation for the stock is Moderate Buy, while the current...

While controversy may have engulfed shares of Medmen Enterprises Inc (OTCMKTS:MMNFF) last month, there’s little question that its operating results and overall growth remain well intact if its financial data is taken as any basis for judgment. As a case in point, the company just announced its consolidated financial results for the second quarter of fiscal 2019 – the 13-week period ended December 29, 2018.

According to the release, the company saw systemwide sales revenue of $29.9 million, which represents at 39.1% sequential quarterly growth rate, gross profit margin improvement of 53% from 45% in the prior quarter due to unrealized gain on changes in fair value of biological assets, and a combined $23.7 million in revenue from its eight retail locations in California, a 28% quarter-over-quarter increase.

Medmen Enterprises Inc (OTCMKTS:MMNFF) frames itself as a company that, together with its subsidiaries, operates in the cannabis space in the United States.

The company cultivates, produces, possesses, uses, and distributes/retails cannabis in the recreational and medicinal cannabis marketplace. As of June 6, 2018, it owned and operated 18 licensed cannabis facilities under the MedMen brand name in California, Nevada, and New York.

The company frames itself as “the preeminent cannabis company in the United States” with multiple assets and operations in California, Nevada, New York, and Florida. MedMen owns and operates licensed cannabis facilities in cultivation, manufacturing, and retail, and is one of the most well-recognized cannabis brands in the world today.

Headquartered in Los Angeles, MedMen employs more than 800 workers across the United States. It was founded in 2010 by Adam Bierman and Andrew Modlin, two visionary entrepreneurs who saw not just a tremendous business opportunity in the growing legalization of marijuana, but a chance to re-define our society’s relationship with cannabis. MedMen supports sensible, clear and just drug laws.

The Company is the single largest financial supporter of progressive marijuana laws at the local, state and federal levels, giving directly to pro-legalization groups, industry organizations and political candidates.

The company is headquartered in Culver City, California. MedMen Enterprises Inc. is a subsidiary of The Medmen Of Nevada 2 Llc.

According to company materials, “MedMen Enterprises is a leading cannabis company in the U.S. with assets and operations across the country. Based in Los Angeles, MedMen brings expertise and capital to the cannabis industry and is one of the nation’s largest financial supporters of progressive marijuana laws.”

Find out when $MMNFF reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.

As noted above, MMNFF just announced its consolidated financial results for the second quarter of fiscal 2019 – the 13-week period ended December 29, 2018.

Traders will note 8% added to share values of the stock over the past week of action. Furthermore, the company has seen interest climb, with an increase in recent trading volume of 35% beyond its prior sustained average level.

“Our strong second quarter results support MedMen’s commitment to drive strong retail and sales performance, while efficiently scaling the Company and executing on our growth strategy,” said Adam Bierman, MedMen chief executive officer and co-founder. “As we emphasized last quarter, we are in a new phase of growth, one focused on continuing to operationalize our industry-leading retail footprint and increasing our profitability. We are confident in the team we’ve built to drive our success.”

Earning a current market cap value of $1.64B, MMNFF has about $12.2M in cash on the books, which must be weighed relative to a mountain of over $86M in total current liabilities. The company has been pulling in significant revenues, with over $7M in Q1 of this year, representing over 630% quarterly y/y growth on the top line. You can bet we will update this one again as new information comes into view. Sign-up for continuing coverage on shares of $MMNFF stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!

Disclosure: we hold no position in $MMNFF, either long or short, and we have not been compensated for this article.

Latest article

The Last Few Sessions Have Southwestern Energy Company (SWN) Soaring

Southwestern Energy Company (SWN) shares are trading at lower $2.89 and the avg recommendation for the stock is Hold, while the current analyst price...

Zynga Inc. (NASDAQ:ZNGA) Stock is Soaring, Here is Why

Zynga Inc. (ZNGA) shares are trading at higher $8.32 and the avg recommendation for the stock is Moderate Buy, while the current analyst price...

Facebook Inc. (FB)’s Stock is Jumping, Here is Why

Facebook Inc. (FB) shares are trading at higher $287.52 and the avg recommendation for the stock is Strong Buy, while the current analyst price...

Can We Expect More Volatility From Sirius XM Holdings Inc. (SIRI)?

Sirius XM Holdings Inc. (SIRI) shares are trading at lower $6.43 and the avg recommendation for the stock is Moderate Buy, while the current...

When Will Cisco Systems Inc. (CSCO) Slow Down

Cisco Systems Inc. (CSCO) shares are trading at higher $43.89 and the avg recommendation for the stock is Moderate Buy, while the current analyst...